School-based telemedicine program reduces asthma symptoms in children

The School-Based Telemedicine Enhanced Asthma Management (SB-TEAM) program was able to improve persistent asthma symptoms in children, according to a study published in JAMA Pediatrics.

Led by Jill S. Halterman, MD, MPH, from the University of Rochester in New York, this study examined the impact of a telehealth program for children with persistent asthma in reducing symptoms and hospitalization.

A total of 400 children with persistent asthma aged 3 to 10 years old were included in the study where they were split into groups enrolled in the SB-TEAM program or a control group receiving enhanced conventional care.

Results showed children in the telehealth group had more symptom-free days and were less likely to visits the emergency department or become hospitalized for asthma than those in the control group. Additionally, 98 percent of the SB-TEAM group children had more than one telehealth visit and 82.5 percent received supervised therapy through their school.  

"The SB-TEAM intervention significantly improved symptoms and reduced health care utilization among urban children with persistent asthma," wrote Halterman and colleagues.  "This program could serve as a model for sustainable asthma care among school-aged children."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup